Programs span familial and sporadic ALS, advancing Arbor’s strategic focus on the diseaseFirst CNS investigational new drug ...

Lillian Chiang, Founder and CEO of Doylestown, Pennsylvania-based Evrys Bio, has received the Timothy M. Block Biotech Impact ...

Epigenetic reprogramming is rewriting what we thought we knew about permanent vision loss.

("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage biotechnology company developing gene therapies designed to ...

Reflector Bio, a New York-based biotechnology startup developing artificial intelligence models for drug discovery, has emerged from stealth with a... Read More ...

KAIST researchers have engineered a hybrid promoter that preserves its relative strength ranking across E. coli and yeast, ...

Five-patient Phase 1b Crohn’s disease cohort showed a 47.5% reduction in mean endoscopic disease activity and a 58.8% reduction in mean fecal ...

Bio-Synergy's DNA + Epigenetics kit measures epigenetic gene methylation ...

Immunotherapy with checkpoint inhibitors has revolutionized cancer therapy and enabled considerable therapeutic advances for ...

Pla2g2f enzyme gene preserves memory with age and resists dementia Lipid-clearing brain enzyme linked to resilient memory and ...

Transcriptome-scale target biology and AI-driven automated chemistry produced a validated lead candidate in weeks, against an industry standard of 12-18 months PALO ALTO, Calif. & MENLO PARK, Calif.-- ...

Researchers at Harvard Medical School's Massachusetts General Hospital have published findings in Nature Neuroscience showing that the ...